Primary small cell carcinoma of the esophagus: progression in the last decade
- PMID: 32395546
- PMCID: PMC7210214
- DOI: 10.21037/atm.2020.03.214
Primary small cell carcinoma of the esophagus: progression in the last decade
Abstract
Primary small cell carcinoma of the esophagus (PSCCE) is a highly malignant tumor that is diagnosed by endoscopic biopsy and immunohistochemistry. Because of its low incidence, a high degree of malignancy, and rapid progress, it is difficult to conduct large, randomized controlled trials and to establish a standard treatment plan for this disease. In recent years, several retrospective studies have been reported, and with the rise of emerging therapies, PSCCE has gradually become a focus of thoracic surgery. This paper reviews progress in the diagnosis and treatment of PSCCE in recent years.
Keywords: Primary small cell carcinoma; esophagus; treatment.
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm.2020.03.214). The authors have no conflicts of interest to declare.
References
Publication types
LinkOut - more resources
Full Text Sources